PROStep: A Feasibility Trial Using PROs and Step Data to Monitor Patients With Lung and GI Cancers
Clinical trial NCT04616768 · COMPLETED
Trial details
- NCT number
- NCT04616768
- Sponsor
- Abramson Cancer Center at Penn Medicine
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-11-19
- Primary completion
- 2021-12-17
- Enrollment
- 108
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.